Class 3 Medicines Recall: Torrent Pharma (UK) Limited, Ramipril 1.25mg tablets, EL(24)A/05
Torrent Pharma (UK) Limited is recalling certain batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.
MDR Number: MDR 022-01/24
Company name: Torrent Pharma (UK) Limited
Product description: Ramipril 1.25mg tablets, PL 36687/0222 SNOMED Code 36834211000001109
Details of the affected batch:
Batch No | Expiry Date | Pack Size | First Distributed |
MG21264 | 29/02/2024 | 28 tablets | 13/12/2021 |
MG21334 | 31/03/2024 | 28 tablets | 30/03/2022 |
MG21335 | 31/03/2024 | 28 tablets | 26/05/2022 |
MG221014 | 30/11/2025 | 28 tablets | 22/03/2023 |
MG221016 | 30/11/2025 | 28 tablets | 16/05/2023 |
MG23488 | 30/04/2026 | 28 tablets | 25/08/2023 |
MG23489 | 30/04/2026 | 28 tablets | 12/09/2023 |
MG23490 | 30/04/2026 | 28 tablets | 12/10/2023 |
MG23729 | 30/06/2026* | 28 tablets | 05/12/2023 |
*amended expiry date
Brief description of problem:
Torrent Pharma (UK) Limited is recalling the above batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.
Advice to Healthcare Professionals:
Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Advice to Patients:
No action is required by patients as this is a Pharmacy and Wholesaler level recall. Patients should continue to take medicines from these batches as prescribed by your healthcare professional. The specified batches are being recalled as a precautionary measure and are unlikely to cause harm if taken.
Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Company contacts for further information:
For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com
For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email: luke.davies@torrentpharma.co.uk or priti.pragji@torrentpharma.co.uk
To access the full recall: Class 3 Medicines Recall: Torrent Pharma (UK) Limited, Ramipril 1.25mg tablets, EL(24)A/05